Margaret A.WinkerMD, Senior EditorIndividualAuthorPhil B.FontanarosaMD, Senior EditorIndividualAuthor
To the Editor.—The Policy Perspective
by Dr Kodish and colleagues1 summarizes
important clinical considerations regarding genetic testing for breast cancer
susceptibility. The authors endorse the statement of the American Society
of Clinical Oncology (ASCO)2 that further
research in this area is essential, but argue that restricting genetic testing
to the research setting may not be in the patient's best interest. In this
regard, it is perhaps worth noting that testing for cancer genetic susceptibility
is now being marketed by more than a dozen commercial laboratories.
Olopade OI, Offit K, Garber JE. Genetic Testing for Susceptibility to Cancer. JAMA. 1998;279(20):1612–1613. doi:10-1001/pubs.JAMA-ISSN-0098-7484-279-20-jbk0527
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: